Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,392 public trials 1,305 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma

NCT01271504

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tucson, Arizona, United States

Fort Myers, Florida, United States

St. Petersburg, Florida, United States

Chapel Hill, North Carolina, United States

View all 24 locations

View Trial Details

Completed

A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)

NCT02859324

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: UCLA Division of Hematology Oncology Los Angeles, California, United States

University of Florida Gainesville, Florida, United States

NYU Langone Medical Center New York, United States

Mary Crowley Cancer Research Dallas, Texas, United States

View all 14 locations

View Trial Details

Completed

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

NCT03546621

Conditions: Chronic Hepatitis D Infection With Hepatitis B, Digestive System Diseases, Hepatitis, +6 more
Locations: Ifi-Institut für interdisziplinäre Medizin an der Asklepios Klinik St. Georg Hamburg, Germany

Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz Hepatologie Hamburg, Germany

Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover Hanover, Germany

UniversitätsKlinikum Heidelberg - Medizinische Klinik, Abteilung Klinische Pharmakologie & Pharmakoepidemiologie Heidelberg, Germany

View all 15 locations

View Trial Details

Completed

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

NCT01041755

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +11 more
Locations: Hospital Universitario "José Eleuterio González" Monterrey, Nuevo León, Mexico

View Trial Details

Completed

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects

NCT04422496

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations: Nucleus Network Pty Ltd Melbourne, Melbourne VIC 3004, Australia

View Trial Details

Completed

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

NCT04546984

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: The Shanghai xuhui district central hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation

NCT02544113

Conditions: Digestive System Diseases, Hepatic Insufficiency, Liver Diseases, +1 more
Locations: Cleveland Clinic Florida Weston, Florida, United States

University of Cincinnati College of Medicine Cincinnati, Ohio, United States

Cleveland Clinic (Main Campus) Cleveland, Ohio, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

NCT01908426

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Corona, California, United States

Los Angeles, California, United States

San Diego, California, United States

San Francisco, California, United States

View all 104 locations

View Trial Details

Completed

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

NCT01473524

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations: UC Davis Medical Center Sacramento, California, United States

Scripps Clinic San Diego, California, United States

University of Colorado, Denver Aurora, Colorado, United States

University of Chicago Chicago, Illinois, United States

View all 59 locations

View Trial Details

Completed

Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency

NCT00157092

Conditions: Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Shands Hospital at the University of Florida Gainesville, Florida, United States

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions